Tag: US Food and Drug Administration

All

Burn Care 3.0: Tissue-Engineered Skin is Regenerative Medicine in Action

According to David H. Ahrenholz, MD, in the December 2015 issue of PSP, the next standard of care for severe burns could be growing patients' own skin.

All

FDA Clears Vivace RF Microneedling System at 2MHz Setting

Aesthetics Biomedical announces that the Vivace RF Microneedling device is now cleared for use at both the 1MHz and the 2MHz frequency.

All

Venus Epileve Receives FDA 510(k) Clearance

Venus Concept Inc has received FDA 510(k) clearance to market and sell the Venus Epileve laser hair removal solution, the company announces.

The Edge: Three far-reaching Internet marketing myths

by Denise Mann | Mar 24, 2015 | Practice Management, Social Media | 0

In April’s Edge, David Evans, PhD, MBA, debunks Internet marketing myths with reality checks.

Take That, Double Chins: FDA Panel Unanimously Backs Kythera’s ATX-101

by Denise Mann | Mar 9, 2015 | Rejuvenation | 0

An FDA advisory panel voted unanimously to approve Kythera’s ATX-101 for the reduction of moderate-to-severe submental fat in adults.

Bridge Builder: William Ju, MD, Helps Build Bridges Between Dermatologists, Industry, and Venture Capitalists

by Denise Mann | Jan 26, 2015 | Acne | 0

Through Advancing Innovation in Dermatology, William Ju, MD, is bringing together investors, venture capitalists, doctors, and scientists to spur the development of new treatments for dermatologic problems.

Hot Stuff: January 2015

by Denise Mann | Dec 30, 2014 | Products | 0

Get the scoop on scar-reducing skin care, beauty oil, IDEAL breast implants, and postsurgery bras in PSP’s January 2015 Hot Stuff.

Tag: US Food and Drug Administration

All

Burn Care 3.0: Tissue-Engineered Skin is Regenerative Medicine in Action

Is Kybella the Next Big Thing? One Surgeon Shares His Insights and Experience with Kybella

FDA Warns Against Injectable Skin-Lightening Products

The FDA Requests Allergan Voluntarily Recall Natrelle BIOCELL Textured Breast Implants and Tissue Expanders from the Market to Protect Patients

FDA Approves MiniTC for Fat Tissue Processing and Other Applications

Hot Stuff: November 2015

FDA Issues Final Guidance for Labeling Recommendations for Breast Implants

Inside Hot Topics: Wendy Lewis takes a deep dive into Hot Topics at Plastic Surgery-The Meeting

FDA Finalizes Guidance on Microneedling Devices

All

FDA Clears Vivace RF Microneedling System at 2MHz Setting

Revance Therapeutics Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection

FDA Clears SkinPen Precision to Treat Neck Wrinkles

Doctors Encourage COVID Vaccination Despite Reports of Cosmetic Facial Filler Swelling

FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma

FDA Approves Wynzora Cream for Adults with Plaque Psoriasis

Soliton Files 510(k) with FDA for RAP Device for the Reduction of Cellulite

All

Venus Epileve Receives FDA 510(k) Clearance

Endo Submits BLA to FDA for Cellulite Treatment

FDA Issues Compliance Warnings to Breast Implant Manufacturers

Sientra Reports the Long-Term Safety and Effectiveness of Silicone Gel Breast Implants with Results from the Largest Core Breast Implant Trial To-Date

Expanding on Breast Tissue Expansion Options: Update on the AeroForm Tissue Expander System

FDA Clears Yolo’s Lipofina for Marketing

Take That, Double Chins: FDA Panel Unanimously Backs Kythera’s ATX-101

Bridge Builder: William Ju, MD, Helps Build Bridges Between Dermatologists, Industry, and Venture Capitalists

Hot Stuff: January 2015